A randomize controlled trial on the efficacy of the cryotherapy for dysgeusia with docetaxel.

A randomize controlled trial on the efficacy of the cryotherapy for dysgeusia with docetaxel. - A randomize controlled trial on the efficacy of the cryotherapy for dysgeusia with docetaxel.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027177

Enrollment

Registered

2017-05-01

Start date

2017-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Include an ice cube into mouth in docetaxel administration as much as possible for (approximately 1 hour). No treatment.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients who receive docetaxel therapy preoperatively or postoperatively in breast cancer patients over 20 years of age.

Exclusion criteria

Exclusion criteria: Patients using polaprezink granules or azulene gargle.

Design outcomes

Primary

Measure	Time frame
The incidence of dysgeusia from docetaxel administration to the next dose.	—

Countries

Japan

Contacts

Public ContactTakayuki Ide

Shinshu University Hospital Department of Pharmacy

tkyk@shinshu-u.ac.jp0263-35-4600

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026